Domů › Rakovina žaludku › Wisconsin › Madison
Klinické studie Rakovina žaludku v Madison, WI
11 studií pro Rakovina žaludku hledá účastníky v lokalitách v Madison a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Probíhá náborFáze 2
- UW Health Carbone Cancer Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Probíhá náborFáze 2/3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Probíhá náborFáze 3
- University of Wisconsin Carbone Cancer Center, Madison
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Probíhá náborFáze 2
- Research Site, Madison
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Probíhá náborFáze 1
- University of Wisconsin - Carbone Cancer Center, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Probíhá náborFáze 1/2
- The Board of Regents of the University of Wisconsin, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Wisconsin- Madison, Madison
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Probíhá náborFáze 1/2
- University of Wisconsin, Madison
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- UW Carbone Cancer Center, Madison
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Probíhá náborFáze 2
- University of Wisconsin, Madison
Studie Rakovina žaludku v jiných městech
- Houston, TX42 studií
- Boston, MA32 studií
- New York City, NY31 studií
- Nashville, TN28 studií
- Baldwin Park, CA22 studií
- Los Angeles, CA22 studií
- Arlington, VA20 studií
- Dallas, TX19 studií
- San Antonio, TX19 studií
- St. Louis, MO18 studií
- Grand Rapids, MI18 studií
- Washington, DC16 studií
Další studie v Madison
- Rakovina prostaty29 studií
- Kolorektální karcinom23 studií
- Rakovina prsu22 studií
- Metastatický karcinom21 studií
- Akutní myeloidní leukemie16 studií
- Nemalobuněčný plicní karcinom16 studií
- Melanom15 studií
- Rakovina (všechny typy)14 studií
- Rakovina vaječníků13 studií
- Rakovina slinivky břišní10 studií
- Rakovina plic10 studií
- Mnohočetný myelom9 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.